A RANDOMIZED STUDY, POSPECTIVE, ON THREE DIFFERENT STRATEGY OF HIV POSITIVE NAIVE FOR THE ANTIRETROVIRAL THERAPY

• Conditions: HIV INFECTION CHRONIC AND NAIVE.VIREMIE > 10.000 COPIE/ML AND/OR CD4< 350 CELL/01; MedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infection

• Registration Number: EUCTR2005-001164-32-IT
• Lead Sponsor: AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-08-07
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Verificare l¡¦efficacia di una terapia antiretrovirale di associazione con lamivudina (3TC) + didanosina (DDI) + efavirenz (EFV) in mono somministrazione giornaliera in confronto a lamivudina (3TC) + didanosina (DDI) + atazanavir/ritonavir (ATZ/rtv) in monosomministrazione giornaliera e a zidovudina (AZT) + tenofovir (TDF) + efavirenz (EFV). La scelta dei pazienti per quanto riguarda l¡¦inizio della terapia antiretrovirale sar&agrave; conforme alle indicazioni delle linee guida nazionali ed internazionali. <br>;Secondary Objective: ;Primary end point(s):